Mérieux Equity Partners, France (MxEP) has agreed to invest EUR 40 million into Swixx Biopharma, Switzerland (Swixx), taking a minority position. SIX listed HBM Healthcare Investments who had invested in Swixx in 2017, will co-invest alongside
Tags :Boris Wenger
The team was led by Markus Vischer (Partner, Corporate/M&A - pictured) and Samuel Lieberherr (Managing Associate, Corporate/M&A) and further included Michael Kündig (Senior Associate, Corporate/M&A), Reto Jacobs (Partner,
Baker McKenzie advised UBS in all legal, regulatory and competition law aspects of the transaction. The team was led by Ansgar Schott (Financial Services - pictured left), Pascal Richard (pictured second left) and Petra Hanselmann (
Baker McKenzie advised G+D in all legal, regulatory and competition law aspects of the transaction. The team was led by Kilian Perroulaz (M&A and Transaction Tax) and Pascal Richard (M&A)
CSL enters partnership with Thermo Fisher Scientific, a global biotechnology company with a dynamic portfolio of life-saving medicines.
The Swiss Similasan Group, which develops and produces homeopathic products and natural cosmetics since 1980, decided to establish a strategic alliance with France-based Laboratoires Thea in the area of eye care products
Deutsche Börse Group’s post-trade services provider Clearstream and Ubs have agreed on a partnership in the investment fund services business segment.